Compare
Cencora, Inc. vs McKesson Corp vs Cardinal Health Inc
| Latest fiscal year | Cencora, Inc. COR | McKesson Corp MCK | Cardinal Health Inc CAH |
|---|---|---|---|
| Year ended | 2025-09-30 | 2026-03-31 | 2026-06-30 |
| Revenue | $321.33B | $403.43B | $254.25B |
| Revenue growth (YoY) | +9.3% | +12.4% | +14.2% |
| Gross margin | 3.6% | 3.6% | 3.8% |
| Operating margin | 0.8% | 1.5% | 1.0% |
| Net margin | 0.5% | 1.2% | 0.7% |
| Net income | $1.55B | $4.76B | $1.71B |
| EPS (Diluted) | $7.96 | $38.38 | $7.23 |
| Operating cash flow | $3.88B | $6.16B | $5.17B |
| Free cash flow | $3.21B | $5.72B | $4.53B |
| Cash & equivalents | $4.36B | $3.98B | $4.86B |
| Total assets | $76.59B | $82.32B | $57.30B |
| Total liabilities | n/a | n/a | n/a |
| Shareholders' equity | $1.51B | -$1.78B | -$2.88B |
| Return on year-end equity | 103.1% | n/a | n/a |
| Shares outstanding | 193.94M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Cencora, Inc. | McKesson Corp | Cardinal Health Inc |
|---|---|---|---|
| Latest | $321.33B Ended 2025-09-30 | $403.43B Ended 2026-03-31 | $254.25B Ended 2026-06-30 |
| 1 year earlier | $293.96B Ended 2024-09-30 | $359.05B Ended 2025-03-31 | $222.58B Ended 2025-06-30 |
| 2 years earlier | $262.17B Ended 2023-09-30 | $308.95B Ended 2024-03-31 | $226.83B Ended 2024-06-30 |
| 3 years earlier | $238.59B Ended 2022-09-30 | $276.71B Ended 2023-03-31 | $204.98B Ended 2023-06-30 |
| 4 years earlier | $213.99B Ended 2021-09-30 | $263.97B Ended 2022-03-31 | $181.33B Ended 2022-06-30 |